A7824
6-アミノカプロン酸
synthetic (organic), ≥99%, antifibrinolytic agent, powder
別名:
ε-アミノカプロン酸, 6-アミノヘキサン酸, EACA
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
化学式:
H2N(CH2)5CO2H
CAS番号:
分子量:
131.17
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352202
EC Number:
200-469-3
MDL number:
Beilstein/REAXYS Number:
906872
Assay:
≥99%
Form:
powder
Grade:
biotech. grade
製品名
6-アミノカプロン酸, BioUltra, ≥99%
biological source
synthetic (organic)
Quality Level
grade
biotech. grade
product line
BioUltra
assay
≥99%
form
powder
technique(s)
cell culture | mammalian: suitable
impurities
≤0.005% Phosphorus (P), ≤0.1% Insoluble matter
ign. residue
≤0.1%
mp
207-209 °C (dec.) (lit.)
solubility
H2O: 0.5 M, clear, colorless
anion traces
chloride (Cl-): ≤0.05%, sulfate (SO42-): ≤0.05%
cation traces
Al: ≤0.0005%, Ca: ≤0.005%, Cu: ≤0.0005%, Fe: ≤0.0005%, K: ≤0.005%, Mg: ≤0.001%, NH4+: ≤0.05%, Na: ≤0.02%, Pb: ≤0.001%, Zn: ≤0.0005%
storage temp.
room temp
SMILES string
NCCCCCC(O)=O
InChI
1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)
InChI key
SLXKOJJOQWFEFD-UHFFFAOYSA-N
Gene Information
human ... PLAT(5327), PLG(5340)
rat ... Ppm1a(24666)
Biochem/physiol Actions
リシン類縁体です。プラスミンを速やかに分解させることで、プラスミノーゲンの活性化とその後の線維素溶解を阻害します。
リシン類縁体です。プラスミンを速やかに分解させることで、プラスミノーゲンの活性化とその後の線維素溶解を阻害します。活性化血小板へのプラスミノーゲンの結合を阻害することが報告されています。初期の報告では、補体第一成分の活性化を阻害することも示されています。カルボキシペプチダーゼBに結合して不活性化させます。
Still not finding the right product?
Explore all of our products under 6-アミノカプロン酸
保管分類
11 - Combustible Solids
wgk
WGK 2
flash_point_f
404.6 - 408.2 °F
flash_point_c
207 - 209 °C
ppe
dust mask type N95 (US), Eyeshields, Gloves
Robert A Gaultney et al.
PloS one, 8(9), e75643-e75643 (2013-10-03)
The causative agent of Lyme disease, Borrelia burgdorferi, codes for several known fibronectin-binding proteins. Fibronectin a common the target of diverse bacterial pathogens, and has been shown to be essential in allowing for the development of certain disease states. Another
Tijana Jovanovic-Talisman et al.
Methods in cell biology, 122, 379-393 (2014-05-27)
In vitro mimics of cellular machines have been recently engineered and utilized to investigate processes within cells. These devices can provide novel insights into biological mechanisms and have the potential to improve biotechnological processes such as separation. In particular, several
Weining Bian et al.
Nature protocols, 4(10), 1522-1534 (2009-10-03)
This protocol describes a cell/hydrogel molding method for precise and reproducible biomimetic fabrication of three-dimensional (3D) muscle tissue architectures in vitro. Using a high aspect ratio soft lithography technique, we fabricate polydimethylsiloxane (PDMS) molds containing arrays of mesoscopic posts with